In Brief
The phenotype of senescent cells is highly heterogeneous, but reasons for this variability are poorly understood. Hernandez-Segura et al. identify senescence transcriptome signatures that are strongly associated with specific stresses and cell types and show that the gene expression profiles of various senescence programs are highly dynamic.
RESULTS AND DISCUSSION
Specific senescence-associated transcriptome programs have been mainly characterized in fibroblasts. We, therefore, constructed a signature based on whole-transcriptome profiles of various strains of human fibroblasts subjected to different senescence-inducing stimuli. To increase statistical power, and limit biases associated with individual studies [11] , we used several datasets generated at different times and in different laboratories, including ours. Only datasets generated using primary fibroblasts without genetic manipulation (with the exception of oncogenic Ras expression in the case of oncogene-induced senescence), with at least two biological replicates, and at least 50% of the cells positive for senescence-associated b-galactosidase (SA-bgal) activity, were included in the analysis (Data S1A). The selected datasets covered 6 different fibroblast strains (BJ, IMR90, HFF, MRC5, WI38, and HCA-2) and 3 different senescence-inducing stimuli (replicative senescence [RS] , oncogene-induced senescence [OIS] , and ionizing radiation-induced senescence [IRIS] ) and were generated by 5 independent laboratories ( Figure 1A ) [12] [13] [14] [15] [16] .
Principal-component analysis (PCA) revealed that the tissue of origin (lung or foreskin) accounted for most of the variation (data not shown). However, the second and third principal components separated the cells according to senescence status, with some influence from the study/dataset of origin ( Figure S1A ). Nonetheless, one sample within one of the datasets (RS IMR90 [14] ) clustered differently from its replicates. The aberrant clustering of this sample was reported in the original study, and this sample was then removed from further analysis ( Figure S1A ).
Each sample showed transcriptional induction of at least some of the known senescence-associated genes, namely, p16INK4A (CDKN2A), p21CIP1 (CDKN1A), GLB1 (SA-bgal), and several senescence-associated secretory phenotype (SASP) factors ( Figure S1B ). Interestingly, our analysis revealed variability due to intra-and inter-laboratory culture conditions ( Figure S1B ).
We first grouped the datasets based on the senescence stimulus ( Figure 1A ). For RS, the only group with more than one dataset, we performed a meta-analysis combining three different methods: we used (1) a negative binomial-generalized linear model (NB-GLM), pooling all the samples in all the datasets for one particular senescence-inducing stimulus and comparing them to proliferating counterparts, and within the model, we included a covariate that accounted for inter-laboratory and inter-strain differences (see STAR Methods for details); (2) an analysis of each individual dataset and subsequent combination of the p values using the Fisher method; and (3) an inverse-normal p value combination technique in which each dataset was weighted according to the number of replicates [17, 18] . We set a stringent threshold of nominal p % 0.01 to reduce the odds of false-positive results and retained only those genes that were differentially expressed by the three different methods. For IRIS and OIS, where only one dataset for each condition was A) Experimental design. Seven RNA-seq datasets obtained from the indicated studies were used to build a stimulus-specific signature and general signature of senescent fibroblasts, regardless of the stimulus. Only genes with a p % 0.01, calculated by the three methods and with expression unchanged or in the opposite direction in quiescence, were included in each signature. The number of genes constituting each signature is displayed in the flower plot. (B) Heatmap of the 1,311 genes in the senescence signature of fibroblasts and the top 10 enriched GO terms. The graph shows the logarithm base 2 of the fold change for each senescence-inducing stimulus tested with respect to proliferating cells. Blue indicates downregulated genes; red indicates upregulated genes. (C) Top 10 enriched pathways in the senescence signature of fibroblasts. The pathways enriched in genes within the senescence signature of fibroblasts (in B) are enlisted with their corresponding p value and source. ER, endoplasmic reticulum. HAT, histone acetyltransferases; KEGG, Kyoto Encylopedia of Genes and Genomes; PID, Pathway Interaction Database. See also Figure S1 and Data S1. available, we used a normal differential expression analysis to select genes (adjusted p % 0.01). To ensure the identification of genes associated with senescence, and not growth arrest per se, we analyzed quiescent (HCA2) fibroblasts and removed from subsequent analysis those genes similarly regulated in both quiescence and each of the senescence conditions.
A number of genes were associated with a specific senescence-inducing stimulus: 1,699 genes with RS, 2,365 genes with OIS, and 647 genes with IRIS (Figures 1A and S1C ; Data S1B-S1D). Of note, the stimulus-specific signature might be influenced by the fact that more than one dataset was available only for RS. However, common differentially expressed genes between the different stimuli were not affected by this variable. Thus, we performed a meta-analysis using the same three methods described for the stimulus-specific signatures but pooled all the datasets available and compared senescent cells (regardless of the stimulus) to proliferating cells. We found that 2,330 genes were differentially expressed by senescent fibroblasts, regardless of the senescence inducer, and half of these genes (1311 genes) were not shared with quiescent cells (Figure 1A ; Data S1E). Within the senescence-associated signature of fibroblasts, multiple genes related to transcription and RNA synthesis were downregulated, while genes involved in vesicle transport were upregulated ( Figure 1B ). Among the main gene ontology (GO) pathways [19, 20] showing altered in senescent cells, ''chromatin organization,'' ''DNA repair,'' ''membrane trafficking,'' and ''activation of NF-kappaB'' were notable for their known links to senescence and aging ( Figure 1C ) ( Figure 1C ) [1, 10, 21, 22] .
An important contributor to the heterogeneity of the senescence program is the expression of cell-type-specific genes [23] . For example, upregulation of various components of the SASP has been reported to be dependent on the type of cell [24] . To identify variability due to cell type and identify genes at the core of the senescence program, we used datasets from melanocytes, keratinocytes, and astrocytes. We used inclusion criteria similar to those used for the fibroblast datasets (Data S2A). The datasets from melanocytes and keratinocytes were obtained in our laboratory: the cells were induced to senescence by IRIS, RNA was collected 10 days after induction, and senescence status was confirmed by SA-bgal activity and growth arrest ( Figure S2A ). The dataset from astrocytes was publicly available, and senescence was induced by oxidative stress [25] (Figure 2A ).
To identify cell-type-dependent and -independent senescence signatures, we compared the lists of differentially expressed genes in the three cell types with the senescence-specific signature derived from fibroblasts ( Figure 2A ; Data S2B-S2E). Celltype-dependent genes were enriched in different GO terms. For instance, few GO terms related to intracellular transport, RNA and/or protein expression, or processing and immune system functions were associated with the different cell types (Figure S2B) . Three of the enriched GO terms for either astrocytes or keratinocytes were associated with differentiation in their tissue of origin (namely, ''neurogenesis'' or ''neuron differentiation'' and ''epithelial cell differentiation,'' respectively).
Importantly, upon examining the list of common differentially expressed genes, we identified a significant number of hits (55 in total; Figure 2B ; Data S2F) comprising a senescence core signature. Remarkably, none of the classical senescence markers (CDKN2A, CDKN1A, LMNB1, and members of the SASP) were among these hits, since either they were not differentially expressed in all the cell types, or they were shared with quiescence ( Figure S2C ). Nevertheless, within the senescence core signature, we found genes that had been previously linked to senescence: BCL2L2 (also known as Bcl-w), a negative regulator of apoptosis [26] ; PATZ1, a transcriptional repressor whose expression inhibits senescence in endothelial cells [27] ; SMO, a component of the Hedgehog pathway [28] ; and CCND1, a regulatory subunit of CDK4 or CDK6, whose activity is required for the G1/S transition [29] . Moreover, a number of other genes in the signature were reported to be implicated in oncogenesis or in known senescence-associated pathways (see Data S2G). In terms of GO and pathway analysis, some of the downregulated genes were associated with DNA binding or regulation of transcription, while upregulated genes were mainly related to DNA damage checkpoints and mitosis ( Figures 2C and 2D ). Of note, most of the genes had a moderate fold change, yet 26 of them changed greater than 1.3-fold in all cell types.
From this senescence-associated core signature, we selected a number of genes for further validation using qPCR and human BJ primary fibroblasts. We induced senescence by various means, including those used in the previous analyses (ionizing radiation, replication, and oxidative stress), as well as doxorubicin, a DNA-damaging chemotherapeutic agent known to cause senescence [30] ) ( Figures S3A-S3D ). Senescence status was confirmed by SA-bgal activity ( Figure S3A ), lack of 5-ethynyl-2'-deoxyuridine (EdU) incorporation ( Figure S3B ), and increased expression of p16INK4a and p21CIP1 (for RS cells; Figure S3C ). Furthermore, to investigate potential conservation among species, we measured the expression of a subset of genes in senescent mouse cells (mouse embryonic fibroblasts [MEFs] or neonatal endothelial cells) (Figures S3E and S3F) . We confirmed the differential expression of these genes under most of the conditions tested, further validating our identification of a senescence core signature. In a few cases, the differential expression of individual genes was not statistically significant, suggesting that a combination of the expression level of senescence core genes might be a much stronger predictor of senescence. Moreover, we identified discrepancies between mouse and human cells for EFNB3, suggesting potential differences in senescence core signatures among species.
To validate the specificity of our senescence core signature and test its validity in predicting senescence in diseased tissues, we analyzed additional datasets. To exclude the possibility that genes in our core signature were predictors of a general response to genotoxic stress, we interrogated published datasets that used mild forms of DNA damage ( [31] ; GEO: GSE80207). Only one gene in our signature (PLK3) was reported differentially expressed in a radiosensitive lymphoblast line 4 hr after exposure to 2 Gy ionizing radiation (false discovery rate [FDR] % 0.05), a dose that causes damage without pervasive permanent cell-cycle arrest. Importantly, this gene was no longer differentially expressed 24 hr or 14 days after the radiation or at any time after radiation in a radioresistant lymphoblast line (data not shown).
To understand whether genes present in the core signature were differentially regulated in diseased and senescence-enriched tissues, we used an RNA sequencing (RNA-seq) dataset from lung tissues of patients with idiopathic pulmonary fibrosis, in which known senescence markers were detected [32] . Strikingly, ten genes in our core signature (DGKA, GBE1, GDNF, KCTD3, MEIS1, PDLIM4, RAI4, SPIN4, TAF13, and TRDMT1) were also present in this dataset (adjusted p % 0.01; data not shown). These findings suggest that even in whole tissues where the number of senescent cells is small (most aged or diseased tissues contained 1%-3% senescent cells [33] ), some of the genes of our core signature can be identified as differentially regulated.
The senescence phenotype, including the transcriptome, is highly dynamic, and not all the common senescence markers appear or persist simultaneously [34, 35] . However, most studies analyze senescent phenotypes 7-10 days after applying the senescence inducers [36, 37] . To explore the temporal dynamics of senescence-associated gene expression, we generated RNA-seq datasets using fibroblasts (HCA-2), melanocytes, and keratinocytes (6 biological replicates each) at 4 (early), 10 (intermediate) and 20 (late) times after ionizing radiation ( Figure 3A ; Data S3A-S3C). We identified 61 genes that were shared among all cell types and time points, 34 of which were not shared with quiescent cells (Figure S4A ; Data S3D). GO annotations and pathway analysis revealed the differential regulation of genes involved in cancer and cell-cycle progression ( Figure 3B ).
We then obtained transcriptomic signatures that were specific for each time point to determine the dynamics of the response to a senescence-inducing stimulus ( Figure 3C ; Data S3A-S3C). Early senescence was characterized by DNA damage response and p53 signaling, perhaps reflecting the first response to the damage caused by the radiation. Intermediate senescence was characterized by metabolic changes (the citric acid cycle and respiratory electron transport), p53-associated pathways, and signaling mediated by p38-gamma and p38-delta, two isoforms of p38-MAPK (mitogen-activated protein kinase) known to have an important role in senescence and the SASP [38] . Notably, only in late senescence were cell-cycle arrest and chromatin remodeling among the top differentially expressed pathways, surpassing other pathways in importance ( Figure 3C ). Interestingly, genes encoding SASP factors showed significant time-point-and cell-type-dependent heterogeneity ( Figure 3D ). This variability highlights the importance of time and cellular identity in determining the SASP and reflects the complexity of its regulation and biological functions [1] .
Finally, we followed, over time, the 55 genes that constituted the senescence core signature ( Figures 2B and 4) . While we found differential expression of all the genes at day 10 for melanocytes and keratinocytes, other time points showed high variability. In the case of fibroblasts, the lack of significance of some genes at day 10 is likely due to the lack of power from using a single dataset, since these genes reached statistical significance only when multiple datasets were pooled. We also validated a subset of these genes in primary human HCA-2 fibroblasts and confirmed differential expression compared to that in proliferating and quiescent cells (Figures S4B and S4C) . Nonetheless, among the 55 genes of the senescence core signature, 13 genes were differentially regulated at every time point and in every cell type (Figure 4 , genes in red).
Many factors can influence the senescence program and the biological functions of senescent cells. Here, we investigated the senescence phenotypes related to 3 main variables: the stress signal, the type of cell, and the time after senescence induction. We found 1,311 genes uniquely differentially regulated in senescent fibroblasts and not quiescent fibroblasts. 55 genes were also shared among four different cell types induced to senesce by four different stimuli. The temporal dynamics of these genes exposed a new layer of complexity, revealing that the senescence signature found is highly time dependent. Nevertheless, we were able to identify 13 genes as differentially regulated in all the conditions considered, including time.
Among the known senescence-associated genes, we identified PATZ1, a transcriptional repressor that inhibits senescence [27] , and CCND1, a regulatory subunit of CDK4 or CDK6 [29] . It is noteworthy that the common senescence markers, CDKN2A, CDKN1A, and LMNB1, were not within the core signature, supporting the idea that known senescence markers lack universality for different cell types and inducers of senescence [10] . Indeed, one of the studies used here [14] showed that p16INK4A mRNA levels are not always significantly changed in senescence in some fibroblast strains. Although RNA levels do not always reflect protein levels, p16INK4A expression is often used as a senescence marker. However, it is possible that samples collected to perform the RNA-seq experiments might have been in a pre-p16INK4A engagement phase, as p16INK4A is often induced late after senescence induction [39] . By contrast, p21CIP1 was among the genes differentially expressed by all senescent cell types and in response to all stimuli, although it was also slightly upregulated in quiescence, concordant with its known involvement in both types of cell-cycle arrest [40] . LMNB1 was strongly downregulated in all cell types, with the exception of melanocytes, but was also somewhat downregulated at quiescence.
Finally, we showed that temporal dynamics strongly influence the detection of differentially expressed genes. In addition to the expression of the genes in our core signature, we included genes encoding known SASP factors ( Figure 3D ), further illustrating the heterogeneity among cell types and time points after signature with genes differentially expressed (p % 0.01) in all three cell types and a shared IR-induced senescence (IRIS) signature with genes shared by all cell types and time points (p % 0.01) were generated. Figure S4 and Data S3.
(legend on next page) senescence induction. These findings emphasize the need to include time as a variable when studying senescence. It is clear, though, that there is, as yet, no universal marker of senescence. Others have proposed the use of multiple markers [10] , and we propose here the use of core transcriptome signatures such as we provide here. These signatures can help identify senescent cells and discriminate among different senescence programs. The number of genes to be tested to achieve precision still needs to be determined, particularly in vivo. However, our data clearly highlight the heterogeneity of senescent cells in culture, anticipating that these challenges might be amplified in vivo, where less is known about the stimuli and cell types associated with senescence.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Each panel shows one of the 55 genes in the core signature at the indicated points before and after irradiation. All genes show a dynamic temporal behavior at the time points tested: day 0 (proliferation), day 4, day 10, and day 20 after irradiation. Notably, all genes show a similar trend in the three cell types tested: fibroblasts (yellow), keratinocytes (red), and melanocytes (magenta). Genes in red correspond to those that reached significance (p % 0.01) at all time points tested. N = 6. *p % 0.05; **p % 0.01. See also Figure S4 and Data S3.
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Marco Demaria (m.demaria@umcg.nl).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell strains and culture Human foreskin fibroblasts HCA2 (male) were obtained from the laboratory of O. Pereira-Smith (University of Texas Health Science Center, San Antonio); human foreskin fibroblasts BJ were purchased from ATCC (Cat: CRL-2522); Human neonatal foreskin epidermal melanocytes and keratinocytes (male) were purchased from ATCC (Cat: PCS-200-012 and PCS-200-010, respectively). HCA2 cells were not re-authenticated by the laboratory, but regularly monitored for mycoplasma contaminations (once/2 weeks). Commercial cells were authenticated by ATCC. Mouse Embryonic Fibroblasts (MEFs -from unknown gender due to developmental stage) were produced from 13.5 day embryos as previously described [41] ; mouse primary skin microvascular endothelial cells (gender not provided by the source) were purchased from Cellbiologics (Cat: C57-6064). All cells were cultured in 5% oxygen and 37C for at least 4 Population Doublings (PD) prior to use and tested regularly for mycoplasma infection. Fibroblasts were cultured in DMEM (Thermo Fisher Scientific) enriched with 10% fetal bovine serum (FBS, GE Healthcare Life Sciences) and 1% penicillin/ streptomycin (Lonza). Endothelial cells were grown in an endothelial cell growth media (ATCC).
METHOD DETAILS
Technical and biological replications are described in the individual methods. Randomization and blinding of most experiments were not possible, but otherwise described. Statistical methods of computation are described in specific paragraphs. Inclusion and exclusion criteria for RNaseq datasets are provided in Data S1A.
Sample preparation
For each condition, 3 biological replicates were generated. Quiescence was induced by culturing the cells for 48 hr in DMEM supplemented with 0.2% FBS. For ionizing radiation-induced senescence (IRIS), cells were subjected to a 10 Gy dose of g-radiation using a 137 Cesium source and medium was refreshed every 2 days. Cells were harvested at day 10 after irradiation for most of the experiments and validations. For the time series, cells were harvested at day 4, 10 and 20 after irradiation. For replicative senescence (RS), cells were propagated in culture for 4 months (re-cultured at 30%-40% density every time they reached 70%-80% confluency) until they stopped growing (PD 65 for BJ cells).
For oxidative stress-induced senescence (OSIS), cells were treated with 200uM of hydrogen peroxide (Sigma Aldrich) for 2 hr, followed by drug removal and culturing in fresh DMEM supplemented with 10% FBS. Treatment was repeated at day 0, 3 and 6, with medium refreshed every 2 days in between, and cells harvested on day 10 after the first treatment.
Doxorubicin (Tebu-bio) was used in a concentration of 250 nM for 24 hr. The medium was then replaced by normal DMEM supplemented with 10% FBS and refreshed every 2 days. Cells were harvested on day 7 after treatment.
Proliferating controls for each condition were generated stimulating cells with the corresponding vehicles and/or considering the same PD of the treated samples. When only one control for multiple conditions is shown, it represents the average of controls for each condition.
SA-bgal assay
Cells were plated in a 24-well plate, fixed in a mixture of gluteraldehyde and formaldehyde (2%/2%) for 10-15 min and stained overnight with an X-Gal solution using a commercial kit (Biovision). Cells were counter-stained with a 1 mg/ml 4 0 ,6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich, D9542) solution for 20 min. Every biological replicate was stained in duplicate, and counting was made in blind.
EdU staining
Cells were cultured for 24 hr in the presence of EdU, and fixed and stain using a commercial kit (Click-iT EdU Alexa Fluor 488 Imaging kit; Thermo Fisher Scientific). Every biological replicate was stained in duplicate, and counting was made in blind. Enriched pathways and Gene Ontology (G.O.) terms in the differentially expressed genes within the ''Fibroblast Senescence signature'' were evaluated by using the online tool ''Over-representation analysis'' of the Consensus Path DB-human (http://cpdb.molgen. mpg.de/) [19, 20] .
Universal Senescence Signature shared in different Cell Types Differential Expression analysis was also performed with DESeq2 for each individual dataset separately and the gene lists of differentially expressed genes were compared to the senescence signature of fibroblasts, without combining their p values. As before, only genes with a p value % 0.01 in every dataset and within the signature of fibroblasts were included in the core senescence signature.
QUANTIFICATION AND STATISTICAL ANALYSIS
SA-bgal assay Images were acquired at 100X magnification, and the number of cells counted by the software ImageJ (http://www.rsbweb.nih.gov/ij/). The number of positive cells was counted manually in blind.
EdU staining
Images were acquired at 400X magnification, quantified using ImageJ (http://www.rsbweb.nih.gov/ij/). In all cases, both for SA-bgal assay and for EdU staining, samples were done in triplicates and at least 100 cells were counted in each replicate (in blind) and corresponding barplots were generated, where error bars represent the Standard Error of the Mean (SEM).
Real Time-PCR Tubulin was used for normalization of the CT values. All samples were run with a technical replicate and in 2-3 biological replicates. An unpaired two-tailed Student's t test was used to determine statistical significance based on delta-CT values. P values of 0.05 or less were considered statistically significant.
DATA AND SOFTWARE AVAILABILITY
Self-generated RNaseq data RNaseq data has been deposited in the ArrayExpress database (http://www.ebi.ac.uk/arrayexpress) under ID code ArrayExpress: E-MTAB-5403.
Plots
All plots were made in R using the following R-packages: ''pheatmap,'' ''ggplot2,'' ''ggfortify,'' ''RColorBrewer'' and ''VennDiagram.''
